Faster, targeted malaria warnings and responses for Amazon communities
Improving Response to Malaria Outbreaks in Amazon-Basin Countries
This project is improving early-warning tools to predict malaria outbreaks so health teams in Amazon countries can act sooner and target prevention.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11166436 on NIH RePORTER |
What this research studies
If I live in the Amazon, researchers are expanding an early-warning system that already predicts outbreaks in Loreto, Peru, to other Amazon regions and countries. They'll link satellite and weather data with Bayesian spatial forecasting and agent-based models of local behavior to predict when and where malaria will rise, including the effects of migration. The project will downscale forecasts to detect local hotspots and work with local health teams to trigger earlier, targeted prevention instead of waiting for delayed surveillance. Field tests in multiple Amazon districts will show whether the improved system works beyond Peru and help refine it for real-world use.
Who could benefit from this research
Good fit: People living in high-malaria areas of the Amazon—especially in border districts and regions like Loreto, Peru—are the intended focus and may be engaged by local health programs.
Not a fit: People living outside Amazon regions or in places with very low malaria risk are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this could help health teams prevent or contain outbreaks sooner and reduce malaria infections in affected Amazon communities.
How similar studies have performed: Their existing Malaria Early Warning System performed well in Loreto, Peru (>90% sensitivity, >75% specificity), but expanding it across countries and adding migration and hotspot downscaling is a new step.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Pan, William Kuang-Yao — Duke University
- Study coordinator: Pan, William Kuang-Yao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.